1. 307 The study design of a trial of dupilumab in adult patients with bullous pemphigoid (BP): LIBERTY-BP ADEPT. (25th January 2023) Authors: Murrell, Dedee F; Joly, Pascal; Werth, Victoria P; Laws, Elizabeth; Mannent, Leda P; Beazley, Bethany; Dubost-Brama, Ariane; Shabbir, Arsalan Journal: British journal of dermatology Issue: Volume 188(2023)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S401 Dupilumab Improves Clinical, Symptomatic, Histologic, and Endoscopic Aspects of EoE, Regardless of Prior Swallowed Topical Steroid Use. (October 2022) Authors: Dellon, Evan; Lucendo, Alfredo; Collins, Margaret; Sun, Xian; Patel, Kiran; Beazley, Bethany; Shabbir, Arsalan Other Names: Bredenoord Albert presenter. Journal: American journal of gastroenterology Issue: Volume 117:Number 10(2022)supplement 10S Page Start: e281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Toward an 'off the shelf' technology for burn victims: healing wounds with mesenchymal stem cells. (May 2015) Authors: Shabbir, Arsalan; Badiavas, Evangelos V Journal: Regenerative medicine Issue: Volume 10:Number 4(2015) Page Start: 381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗